𧬠COVID Mortality Risk Estimator
Age-stratified estimates with comorbidity adjustments. Read the caveats.
Educational estimates from published early-pandemic data with major caveats. Not medical advice; discuss personal risk with your clinician.
COVID mortality risk is dominated by one variable, age, with vaccination and health conditions adjusting it. This estimator starts from published age-stratified infection fatality rates, applies comorbidity multipliers and vaccine protection, and shows the result with its caveats printed large. The numbers describe populations, not your personal fate.
How to Use This Estimator
Select your age group, check health factors, and set vaccination status. Read the estimate and then the caveats, which are part of the result.
Choose the age band. Age drives the base rate more than everything else combined.
Check cardiopulmonary disease/diabetes, immunocompromise, and obesity. Each multiplies risk by about 1.5x in this simplified model.
Set vaccination status. Then read the caveats: variant, timing, and care quality all move the real number.
The Numbers and Where They Come From
The base rates are the CDC's early-pandemic "current best estimates" of infection fatality ratio by age, the fraction of all infections (not just diagnosed cases) resulting in death. They describe an unvaccinated population facing the original strain with 2020-era care. Everything since, variants, vaccines, prior immunity, better treatment, pushes real-world risk down, some of it captured by the vaccine factor, the rest in the caveats. The 0.5x-per-condition multiplier is a simplification of published hazard ratios, which cluster around 1.3-2x per major comorbidity.
Age dominates because immune senescence and comorbidity burden rise with it: the 65+ base rate is 270 times the 18-49 rate. That ratio is the single most important fact about COVID risk stratification, and it has held across every variant. Vaccination compresses absolute risk enormously while leaving the age ordering intact.
Worked Example
A 70-year-old, vaccinated, with diabetes: base 5.4% x 1.5 (one condition) x 0.25 (vaccine) = 2.03% estimated IFR. Unvaccinated with the same profile: 8.1%. A 30-year-old vaccinated with no conditions: 0.02% x 1.0 x 0.25 = 0.005%, or 1 in 20,000 infections. The examples show both levers: age sets the order of magnitude, vaccination divides it. Neither number is a personal prediction; both are population estimates with wide uncertainty.
Caveats That Are Part of the Answer
Variant matters: Omicron-era severity runs lower than the ancestral strain these bases describe. Immunity wanes: a booster two years ago is not a booster last month. Treatment matters: antivirals like Paxlovid cut progression risk in high-risk patients, and care quality varies. The comorbidity multiplier is crude: well-controlled diabetes differs from end-organ disease, and "65+" spans the vigorous 66-year-old and the frail 90-year-old. Long COVID, the morbidity that matters most to younger people, is not in this mortality number at all.
Use the estimate for calibration, not comfort or fear. If it says 2 percent, that means 98 in 100 similar infections survive, and it also means the risk is 400 times a young healthy adult's: both true, both relevant. Personal decisions, boosters, antivirals, precautions around vulnerable people, belong with your clinician, who knows your specific conditions. For the exposure half of the equation, see our event risk estimator.
What Actually Protects People Now
Stay current on boosters, especially over 65 or immunocompromised. High-risk patients should know about antivirals in advance: Paxlovid works best started within days of symptoms, so having a plan beats scrambling sick. Ventilation, masks in surges, and staying home when ill protect others. None of this is new, which is the point: the tools that worked in 2021 work now, and the people at highest risk are the ones who most need them used consistently.
Related Calculators
Keep exploring: try our COVID event risk and cardiovascular risk for the next piece of the picture.
For informational purposes only, not medical advice. Consult a healthcare professional.
Frequently Asked Questions
What is the COVID death rate by age?
Early-pandemic CDC planning estimates of infection fatality ratio: under 18 ~0.003%, 18-49 ~0.02%, 50-64 ~0.5%, 65+ ~5.4%, unvaccinated. Vaccination, prior immunity, variants, and treatment have lowered real-world risk since; age ordering remains.
What is infection fatality rate (IFR)?
Deaths divided by all infections, including undiagnosed ones. It is lower than the case fatality rate (deaths per diagnosed case) because many infections are never diagnosed. IFR is the better measure of personal risk if infected.
How much do vaccines reduce COVID death risk?
Enormously: vaccination cut mortality risk several-fold in every age group during the major waves, with boosters restoring waning protection. This estimator uses illustrative factors (0.25 vaccinated, 0.15 hybrid); real protection varies by timing and variant.
Which health conditions raise COVID risk most?
Advanced age dominates. Then: cardiovascular disease, chronic lung disease, diabetes, kidney disease, immunocompromise, obesity, and cancer. Multiple conditions compound. Well-controlled single conditions raise risk less than severe or multiple ones.
What is the COVID survival rate?
Over 99% for most age groups under 65; the estimated IFR table above converts directly (survival = 100% - IFR). But survival is not the whole story: hospitalization and long COVID matter, especially for younger people.
Does Paxlovid reduce death risk?
In high-risk patients, trial and observational data show substantial reductions in hospitalization and death when started within days of symptoms. Eligible high-risk patients should have an access plan before getting sick. Discuss with your clinician.
How accurate are COVID risk calculators?
They estimate population averages with wide uncertainty: variant, immunity timing, treatment access, and individual frailty all shift personal risk. Treat outputs as calibration, not prediction.
Is COVID still dangerous in 2026?
For most vaccinated healthy adults, individual risk is low, but it remains a meaningful threat to the elderly, immunocompromised, and unvaccinated, and it still hospitalizes thousands weekly in the US. Risk is concentrated, not gone.
What is long COVID risk?
A significant minority of infections lead to persistent symptoms (fatigue, brain fog, dysautonomia), with risk higher after severe illness but occurring after mild cases too. Vaccination modestly reduces long COVID risk. It is the main morbidity concern for younger adults.
Should I still get boosters?
Public health agencies continue recommending updated boosters, especially for 65+, the immunocompromised, and those with high-risk conditions. Protection against severe disease is the primary goal. Discuss timing with your clinician.